Product news

Share this article:
Johnson & Johnson's anemia drug Procrit has been linked to death in some patients, according to a new study. In the study, which was designed and initiated by a German scientist, more patients treated with Eprex (Procrit's name outside the US) died than in the comparison group receiving a placebo.
Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.